Rate control drugs differ in the prevention of progression of atrial fibrillation

AIMS: We hypothesize that in patients with paroxysmal atrial fibrillation (AF), verapamil is associated with lower AF progression compared to beta blockers or no rate control. METHODS AND RESULTS: In this pre-specified post hoc analysis of the RACE 4 randomized trial, the effect of rate control medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koldenhof, Tim, Wijtvliet, Petra E P J, Pluymaekers, Nikki A H A, Rienstra, Michiel, Folkeringa, Richard J, Bronzwaer, Patrick, Elvan, Arif, Elders, Jan, Tukkie, Raymond, Luermans, Justin G L M, van Kuijk, Sander M J, Tijssen, Jan G P, van Gelder, Isabelle C, Crijns, Harry J G M, Tieleman, Robert G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892061/
https://www.ncbi.nlm.nih.gov/pubmed/34414430
http://dx.doi.org/10.1093/europace/euab191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892061/
https://www.ncbi.nlm.nih.gov/pubmed/34414430
http://dx.doi.org/10.1093/europace/euab191

Ejemplares similares